About Us

About Us

About Canis Majoris Diagnostics

Canis Majoris Diagnostics is a branch of Canis Majoris Financial Services. A dedicated division was created in 2019 to help clients receive financial products related to poor health. Part of that service was health-screening clients with diagnostics testing for specific cancers, heart disease and diabetes. 

In late 2019 a new strain of coronavirus (SARS-CoV-2) swept through the world triggering a Global pandemic. Acknowledgement of our strong relationships with diagnostics manufacturers placed us in a fortunate position. We leaned on our suppliers to deliver a test that was fast, accurate and affordable to combat SARS-CoV-2 virus.

The main principles for Canis Majoris Diagnostic tests of the SARS-CoV-2 virus were speed, accuracy, reliability and affordability. “SARA” a designed company acronym refers to SARS-CoV-2 control whereby speed was at the essence and that high accuracy results was a must. For trust in the diagnostics test it had to be reliable working as expected and made affordable to almost all budgets.

In March 2020 Canis Majoris Diagnostics launched a new patient point of care Antibody test that could detect post infection of SARS-CoV-2 virus in 15 minutes. The test has ratings of 96.9% accuracy and is half the cost of most other leading brands.  

Every day we have been increasing our knowledge of the SARS-CoV-2 virus – its strengths and weaknesses and in September 2020 we have launched another new test based on the advancements we have gained in the last several months.

The new patient point of care Antigen test can detect present infection of SARS-CoV-2 virus in 15 minutes. The test has ratings of over 95% accuracy and is up to 90% less in price compared to current methods of testing present SARS-CoV-2 infection. (RT-PCR Testing)

The incredible SARS-CoV-2 products that are supplied by Canis Majoris Diagnostics match our design of “SARA” and as a company we are always looking to improve.

  • Speed
  • Accuracy
  • Reliability
  • Affordability

A little about our manufacturers

The British and American in vitro diagnostics manufacturers deliver the highest standards of accreditation in both factory assembly and product delivery. Collectively our manufacturers hold arrange of worldwide recognised certifications.

 

Canis Majoris Diagnostics has combined the science of both British and American immunology to deliver less invasive dual testing for SARS-CoV-2 virus that gives qualitative yes/no result within 15 minutes.

History

2017
2017

Canis Majoris was incorporated with a vision to modernise the approach of financial & health care services - establishing new relationships with 3rd party introducers were one of the core business goals.

2018
2018

The innovation to support those with underlying health conditions was apparent through the various industry sectors we cooperated with. This provided a unique approach to our clients’ needs and clearer insight to customer requirements.

2019
2019

Formed new relationships with diagnostics manufacturers to aid the application of financial products for those who had underlying health conditions.

2020
2020

New direction of diagnostics testing created to combat the SARS-CoV-2 global pandemic virus. 

March 2020
March 2020

Launched new Antibody test that can detect post infection of SARS-CoV-2 virus in 15 minutes. The product released provides accuracy of 96.9% and is half the price compared to other leading brands. 

September 2020
September 2020

Launched a new Antigen test that can detect present infection of SARS-CoV-2 virus in 15 minutes. The Antigen test has accuracy of over 95% and compared to RT-PCR testing is up to 90% less in cost.

Vision

The vision is to provide the latest technological and medical advances were speed, accuracy reliability and affordability are in demand for diagnosing infectious diseases. Canis Majoris vision is to expand the testing availability to private industry sectors enabling companies to preform safe and economic sustainability. 

Values

Trustworthy

Trust to us is the belief and confidence in the integrity, reliability and fairness of the organisation and the people therein.

Integrity

Our view on integrity sets a standard to inspire others in being honest and fair in all aspects of the business operation.

Honest

Honesty is fundamental in all our business communications and this echoed throughout the business team. Honesty is our policy.

Transparent

We believe that transparency in all interactions is important. We are confident in the processes we deliver, and we Trust those who work with us.

Empathy

We want to demonstrate to our staff, clients and partners that we can emotionally understand what the other person feels and see things from their point of view.

Teamwork

Our company profits most when everyone is working together and smoothly as a team. It is essential practice that our teams are valued and respected and listen to at all levels.

Health & Safety

Health and Safety is critical to Canis Majoris success as a company. We are committed to a safe and healthy work environment for our staff, our clients and our partners.

Sustainability

We will always aim to streamline our processes to make them as efficient and environmentally friendly as possible. We will work with our partners to encourage these same values.

Mission

The strategy is to grow internationally, and this is made possible through the business partners we collaborate with. Our mission is to work with other distributors that value the same standards to achieve success in agreed territories Worldwide.

About Mission

Mission

The strategy is to grow internationally, and this is made possible through the business partners we collaborate with. Our mission is to work with other distributors that value the same standards to achieve success in agreed territories Worldwide.

About Mission